Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Mills

Showing results (201-210 of 242) with videos related to

Pageof 25
Sort By:
Annals of the New York Academy of Sciences|May 20, 2000
Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancerX Fang, D Gaudette, T Furui, et al.
Cell Death & Disease|July 3, 2015
Metabolic stress induces a Wnt-dependent cancer stem cell-like state transitionE Lee, J Yang, M Ku, et al.
Oncogene|October 7, 2014
P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancerL M Dillon, J R Bean, W Yang, et al.
Oncogene|April 19, 2011
Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibitionB N Rexer, A-J L Ham, C Rinehart, et al.
Oncogene|August 26, 2014
hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressivenessM J Choi, K H Cho, S Lee, et al.
Oncogene|December 22, 1999
The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cellsY Lu, Y Z Lin, R LaPushin, et al.
Oncogene|September 22, 2010
Vimentin is a novel AKT1 target mediating motility and invasionQ-S Zhu, K Rosenblatt, K-L Huang, et al.
Oncogene|July 12, 2011
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal fillingC-R Pradeep, W J Köstler, M Lauriola, et al.
Oncogene|May 10, 2016
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironmentJ Turpin, C Ling, E J Crosby, et al.
Oncogene|June 14, 2011
Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signalingY Lu, M Muller, D Smith, et al.
Pageof 25

Showing results (201-210 of 242) with videos related to

Sort By:
Pageof 25
Annals of the New York Academy of Sciences|May 20, 2000
Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancerX Fang, D Gaudette, T Furui, et al.
Cell Death & Disease|July 3, 2015
Metabolic stress induces a Wnt-dependent cancer stem cell-like state transitionE Lee, J Yang, M Ku, et al.
Oncogene|October 7, 2014
P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancerL M Dillon, J R Bean, W Yang, et al.
Oncogene|April 19, 2011
Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibitionB N Rexer, A-J L Ham, C Rinehart, et al.
Oncogene|August 26, 2014
hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressivenessM J Choi, K H Cho, S Lee, et al.
Oncogene|December 22, 1999
The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cellsY Lu, Y Z Lin, R LaPushin, et al.
Oncogene|September 22, 2010
Vimentin is a novel AKT1 target mediating motility and invasionQ-S Zhu, K Rosenblatt, K-L Huang, et al.
Oncogene|July 12, 2011
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal fillingC-R Pradeep, W J Köstler, M Lauriola, et al.
Oncogene|May 10, 2016
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironmentJ Turpin, C Ling, E J Crosby, et al.
Oncogene|June 14, 2011
Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signalingY Lu, M Muller, D Smith, et al.
Pageof 25